Living on the Spectrum cover
Living on the Spectrum

Living on the Spectrum

About

A public-facing conversational podcast exploring autism, ADHD, Sensory Processing Disorder (SPD), Developmental Language Disorder (DLD), and other neurodevelopmental differences. We curate the latest findings from research and community discussions, turning complex information into clear, dual-host dialogues. Our mission is to bridge the gap between clinical labels and real life, highlighting the overlaps and connections within the neurodivergent community.

Listen

When a small comment feels like rejection: adult ADHD, rejection sensitive dysphoria, and hiding yourself

A genetically modified macaque may be the most concrete test of autism research’s future—not just whether the model works, but whether the people and facilities needed to run it survive. Topics: CHD8 macaque: what primate models can show that mice cannot Oregon primate center downsizing and fragile research infrastructure Rejection sensitive dysphoria: criticism, self-hiding, boundaries ADHD and winter depression: 27% vs 3%, light therapy, screen timing An ADHD essay arguing time isn’t broken, just unorthodox The real cliffhanger: can the next generation of researchers afford to wait—or rebuild?

Overview

This episode discusses a Transmitter report on primate autism research and ADDitude pieces on rejection sensitive dysphoria (RSD), winter depression and ADHD, and an unorthodox concept of time. The conversation separates research findings from lived-experience accounts and educational information, and notes where the material has limits.

Autism research involving monkeys contends with uphill battle

The Transmitter’s Diana Kwon, published November 2, 2026, reports on the first macaque with a CHD8 variant, born in September 2025. CHD8 is linked to autism, co-occurring intellectual disability and macrocephaly. David Amaral at UC Davis has worked with the Oregon National Primate Research Center since 2020; his team is tracking the monkey’s behavior and brain scans over time.

Researchers argue macaques and marmosets can recapitulate core autism traits better than mice. Guoping Feng at MIT notes that mice lack some autism-linked brain regions, such as the dorsolateral prefrontal cortex, and do not reliably model social deficits. With SHANK3, monkeys carrying one altered copy of the gene—unlike mice carrying one altered copy—show sleep disturbances, atypical social interactions, cognitive impairment, repetitive behaviors and altered connectivity between brain regions, paralleling people who carry SHANK3 variants.

Amaral estimated ten genetically modified monkeys would be needed to adequately explore megalencephaly. The Oregon center is central to the work, but after negotiations about possibly becoming an animal sanctuary it plans to downsize and pivot toward nonanimal models; it is unclear which monkey research will continue. Oregon also has an artificial reproductive technology core that other U.S. primate centers do not have. Michael Platt warns that funding cuts or delays could force labs to let go of specialized staff or depopulate a primate colony, and rebuilding is extremely difficult. Zhonghua Lu says the latest SHANK3 monkey study, covering fifteen animals, required eight full-time technicians and engineers.

The article also describes international work. China’s 2022 Brain Project—five billion yuan, about $750 million—put nonhuman primate studies at its core, and there is a long-running MIT collaboration in Shenzhen on SHANK3 macaques. Japan has focused a national project on marmoset brain mapping. Lu says funding for primate projects can be harder to get now even in China, especially as the government favors brain-computer interface research.

Organoids and other in-vitro models have advanced, and some researchers use intraoperative recordings in humans. But some studies—especially gene therapies—still require living animals, at least for now. Feng used SHANK3 macaque and marmoset models to test a therapy that injects a functional SHANK3 minigene into the central nervous system; he says it gave critical safety and efficacy data and is licensed to Jaguar Gene Therapy for a clinical trial. Feng says they are not claiming a monkey model is required, but that it gives confidence. He also says no model is perfect—“not even a human is a perfect model for another human.” The ethics remain unresolved. Amaral says if the project loses access to Oregon it could end prematurely, and that it would be a “very hard sell” for younger investigators because grants are hard to get and the work may not look fundable long term.

The episode frames this as context for why science news can move slowly or stop suddenly, not as individual guidance for families.

The Most Painful Consequence of RSD? Losing Yourself

Related ADDitude item: Alex Partridge on RSD: Live Conversation with ADDitude.

ADDitude published Nathaly Pesantez’s article, updated October 14, 2026, about a live conversation with Alex Partridge—entrepreneur, host of ADHD Chatter and author of Why Does Everybody Hate Me? He was diagnosed with ADHD at 34. He describes RSD as intense reactions to rejection or criticism that is real, perceived or anticipated: “tremendously angry,” “mental health spirals,” “deep, deep sadness,” “total emotional eclipse.”

Partridge says the most painful consequence was not a single argument but losing his sense of self and becoming lonely. He describes hiding himself so only “a version” of him interacted with the world, linking this to persistent negative feedback; repeated criticism makes revealing your authentic self feel risky—“it’s safer to be less of yourself.” The article cites a widely cited estimate that people with ADHD receive 20,000 negative or critical messages by their early teens, likely far more than neurotypical peers. The article gives no source or method, so this is not a precise count. Partridge describes reacting to a partner as if speaking to “the 20,000 people”—past messages rather than the partner.

He also tells of a woman in recovery from alcohol addiction who relapsed after an RSD episode. Her boss emailed, “Have a lovely weekend. Can we have a chat on Monday morning?” She believed she would be fired; on Monday her boss offered her a promotion. Partridge says without context and clarity RSD can be a “brutal full-body experience,” and the article presents the story as an illustration, not verified research.

The coping strategies he describes are lived-experience tools, not a clinical protocol: naming his RSD “Dave the Dragon” to create distance; planning an exit or break before triggering social situations; and trying to explain what fueled a reaction while acknowledging its impact on the other person. He says RSD made him afraid to assert boundaries because he did not want to upset anyone, so he would say yes to things he did not want to do; the short-term relief of avoiding conflict can create long-term resentment or exhaustion. The article is a personal account from a live conversation, not a clinical study with methods or sample data. The episode notes the value may be in recognizing the pattern—not self-diagnosing from a podcast—and bringing it to a clinician if it affects relationships or safety. ADDitude’s standard note says the article is educational only and does not provide medical advice, diagnosis or treatment.

Shedding Light on Winter Depression

ADDitude’s Q&A by psychiatrist J.J. Sandra Kooij discusses an association between seasonal affective disorder and ADHD. In a Netherlands study, 259 patients with ADHD were asked about seasonal mood swings; 27% reported winter depression compared with 3% of neurotypical people. The article says females are four times more likely than males to have winter depression. The episode cautions that this is one survey, and the article does not give full details about design or generalizability, so it is a signal rather than a universal rule.

The article says about 80% of people with ADHD are late sleepers. It discusses light therapy: a 10,000-lux lamp for 30 minutes a day for 5 to 20 consecutive days, close to the eyes because distance affects intensity, preferably between 7 and 8 a.m. to help reset the biological clock. Light therapy glasses work similarly while dressing or eating breakfast. The article calls light therapy a serious antidepressant that often improves mood, sleep and energy, but it does not discuss side effects, contraindications or supervision. The episode frames this as educational information, not a do-it-yourself prescription; anyone considering light therapy should talk with a qualified clinician first. Vitamin D is generally low in people with ADHD for unknown reasons, and supplementation is recommended if levels are too low; this does not establish that low vitamin D causes ADHD symptoms or winter depression.

On screens, the article says children with ADHD who are late sleepers and have winter depression may turn to video games and the internet. Screens emit blue light and are often held close to the eyes, so the article says the effects are similar to light therapy if stared at for a while—an analogy, not a claim that screens equal prescribed treatment. Screen use at night can delay circadian rhythms; because many children with ADHD are already late sleepers, screen use after 9:30 p.m. will delay their rhythm further and is not recommended. The Q&A asks whether ADHD winter depression is more severe, but the text provides prevalence data and an association; it does not present direct evidence that it is more severe in ADHD.

“Your Concept of Time Is Not Broken, Just Unorthodox”

ADDitude’s guest blog by Kama Jensen argues that ADHD time difficulties are not simply a deficit but an unorthodox relationship with time rooted in natural rhythms. She pushes back on “time blind” and suggests clocks can be tools while preserving natural time zones. This is an advice essay, not research. She explicitly disagrees with most ADHD coaches who say time tools must be everywhere; that is her stated view, not a settled consensus. The episode notes that the reframe does not excuse missing every appointment—the article says people still have to communicate with modern timekeeping—and that it is about reducing shame, not abandoning tools.

None of this is individual medical advice. Original article links are on the episode page.

Podcast Transcript

Aaron: Welcome to Living on the Spectrum. I'm Aaron, and with me is Jamie. Today we're starting with a story that sounds like science fiction but is a funding and policy story: the first macaque monkey with a CHD8 variant, born in September 2025, and the question of whether the lab work around it can continue.

Jamie: And CHD8 matters because it's a gene linked to autism, and also to co-occurring intellectual disability and an unusually large head—macrocephaly. The researcher behind that first animal is David Amaral at UC Davis. He's been working with the Oregon National Primate Research Center since 2020, and his team is now tracking the monkey's behavior and brain scans over time.

Aaron: Why a monkey? I think a lot of listeners hear "animal model" and either picture mice or immediately have an ethical reaction. What does the article say this model can do that a mouse can't?

Jamie: The Transmitter piece by Diana Kwon, published November 2, 2026, lays out the case. Researchers argue macaques and marmosets can recapitulate core autism traits better than mice. Guoping Feng at MIT points out that mice lack some autism-linked brain regions, such as the dorsolateral prefrontal cortex, and don't reliably model social deficits. And with SHANK3, monkeys carrying one altered copy of the gene—unlike mice carrying one altered copy—show sleep disturbances, atypical social interactions, cognitive impairment, repetitive behaviors, and altered connectivity between brain regions, paralleling what's seen in people who carry SHANK3 variants.

Aaron: So it's not "monkeys are better" in some abstract way. It's specific questions about brain regions, social behavior, sleep. But the article is also candid that this is hard, expensive, and uncertain.

Jamie: Right. Amaral estimated they'd need ten genetically modified monkeys to adequately explore megalencephaly. The Oregon center is central—Amaral says much of the work happens there—but after negotiations about possibly becoming an animal sanctuary, it plans to downsize and pivot toward nonanimal models. It's unclear which monkey research will continue. Oregon also has an artificial reproductive technology core that doesn't exist at other U.S. primate centers.

Aaron: That feels like the everyday question underneath the science: what happens when the infrastructure disappears? Not just one experiment, but the people who know how to do it.

Jamie: Exactly. Michael Platt warns that funding cuts or delays could force labs to let go of specialized staff or even depopulate a primate colony, and rebuilding after that is extremely difficult. Zhonghua Lu says the latest SHANK3 monkey study, covering fifteen animals, required eight full-time technicians and engineers. A model is also a team.

Aaron: The article mentions China and Japan. Is this becoming a story about international competition?

Jamie: Partly, but it's not a simple race. China's 2022 Brain Project—five billion yuan, about $750 million—put nonhuman primate studies at its core. There's a long-running MIT collaboration in Shenzhen on SHANK3 macaques, and Japan has focused a national project on marmoset brain mapping. But Lu says even in China funding for primate projects can be harder to get now, especially as the government favors brain-computer interface research.

Aaron: What about alternatives? Organoids and other in-vitro models come up. Does that make monkey work obsolete?

Jamie: Not yet. Organoids and other in-vitro models have advanced, and some researchers use intraoperative recordings in humans. But some studies—especially gene therapies—still require living animals, at least for now. Feng used SHANK3 macaque and marmoset models to test a therapy that injects a functional SHANK3 minigene into the central nervous system. He says they gave critical safety and efficacy data, and it's licensed to Jaguar Gene Therapy for a clinical trial. Feng says they're not claiming a monkey model is required, but that it gives confidence.

Aaron: I appreciate that nuance. And he also says no model is perfect—"not even a human is a perfect model for another human." That doesn't resolve the ethics, but it explains the scientific reasoning.

Jamie: It also doesn't resolve the policy. The article leaves open whether Amaral's project keeps access to Oregon. He says if they lose it, the project could end prematurely, and that it would be a "very hard sell" for younger investigators because grants are hard to get and the work may not look fundable long term.

Aaron: So the takeaway for me is not "this will cure autism" or "this is doomed." It's that a very particular kind of research is hanging on facilities, funding, and trained people—and the timeline is genuinely uncertain.

Jamie: Right. And for families, this isn't something to act on individually. It's context for why science news can move slowly or suddenly stop.

Aaron: Let's shift to something much more immediate for a lot of people: rejection sensitive dysphoria, or RSD. Jamie, this next piece is a lived-experience interview, not a clinical trial. Can you set it up carefully?

Jamie: Yes. ADDitude published an article by Nathaly Pesantez, updated October 14, 2026, about a live conversation with Alex Partridge. He's an entrepreneur, host of the ADHD Chatter podcast, and author of Why Does Everybody Hate Me? He was diagnosed with ADHD at 34. He describes RSD as intense reactions to rejection or criticism that is real, perceived, or anticipated—"tremendously angry," "mental health spirals," "deep, deep sadness," "total emotional eclipse."

Aaron: The part that hit me is that he says the most painful consequence wasn't a single argument. It was losing his sense of self and becoming lonely. He described hiding himself so only "a version" of him interacted with the world.

Jamie: And he links that to persistent negative feedback. He says repeated criticism makes revealing your authentic self feel risky—"it's safer to be less of yourself." The article cites a widely cited estimate that people with ADHD receive 20,000 negative or critical messages by their early teens, likely far more than neurotypical peers. But it gives no source or method, so that's not a precise count.

Aaron: Good flag. It's evocative, though. He describes reacting to a partner as if speaking to "the 20,000 people"—not actually his partner, but all those past messages. That's a powerful way to explain why a small comment can feel huge.

Jamie: He also tells a story about a woman in recovery from alcohol addiction who relapsed after an RSD episode. Her boss emailed, "Have a lovely weekend. Can we have a chat on Monday morning?" She believed she'd be fired. On Monday, her boss offered her a promotion. Partridge says without context and clarity, RSD can be a "brutal full-body experience" and it was enough to derail her sobriety. The article presents that as an illustration, not verified research.

Aaron: That's a serious example, and I don't want us to turn it into a lesson about willpower. It sounds more like ambiguity can be genuinely dangerous for some people, and clear communication can reduce the load.

Jamie: The coping strategies he describes are optional tools, not prescriptions. He names his RSD "Dave the Dragon" to create distance. He plans an exit or break before triggering social situations. And he tries to explain what fueled a reaction while acknowledging its impact on the other person. Those are lived-experience strategies, not a clinical protocol.

Aaron: The one I want to ask about is boundaries. He says RSD made him afraid to assert boundaries because he didn't want to upset anyone, so he'd say yes to things he didn't want to do. That's such a relatable trap: the short-term relief of avoiding conflict creates long-term resentment or exhaustion.

Jamie: Right—and to be clear, this is a personal account from a live conversation, not a clinical study with methods or sample data. So these are strategies that helped him, not a protocol that's been tested for everyone. For listeners, the useful piece might be recognizing the pattern—not self-diagnosing from a podcast, but maybe bringing it to a clinician if it's affecting relationships or safety.

Aaron: Right. And the article ends with ADDitude's standard note that it's educational only and doesn't provide medical advice, diagnosis, or treatment. We'll keep that same boundary.

Jamie: There's one more research-adjacent piece worth covering: winter depression and ADHD. The ADDitude Q&A is by psychiatrist J.J. Sandra Kooij. It says there's an association between seasonal affective disorder and ADHD. In a Netherlands study, 259 patients with ADHD were asked about seasonal mood swings; 27% reported winter depression compared with 3% of neurotypical people. The article says females are four times more likely than males to have winter depression.

Aaron: Those are striking numbers. But I want to be careful: 27% versus 3% is a big difference, but it's one survey, and the article doesn't give full details about design or generalizability. So it's a signal, not a universal rule.

Jamie: Exactly. The article also says about 80% of people with ADHD are late sleepers. It discusses light therapy: a 10,000-lux lamp for 30 minutes a day for 5 to 20 consecutive days, close to the eyes because distance affects intensity, preferably between 7 and 8 a.m. to help reset the biological clock. Light therapy glasses work similarly while dressing or eating breakfast.

Aaron: That's a lot of specifics. Is this something people should just try?

Jamie: The article calls light therapy a serious antidepressant that often improves mood, sleep, and energy. But it doesn't discuss side effects, contraindications, or supervision. So this is educational information, not a do-it-yourself prescription—anyone considering light therapy should talk with a qualified clinician first. Vitamin D is generally low in people with ADHD, reason unknown; supplementation is recommended if levels are too low. It doesn't establish that low vitamin D causes ADHD symptoms or winter depression.

Aaron: What about screens? I've seen a lot of parents worry about blue light.

Jamie: The article says children with ADHD who are late sleepers and have winter depression may turn to video games and the internet. Screens emit blue light and are often held close to the eyes, so the article says the effects are similar to light therapy if stared at for a while. But that's an analogy, not a claim that screens equal prescribed treatment. It says screen use at night can delay circadian rhythms, and because many kids with ADHD are already late sleepers, screen use after 9:30 p.m. will delay their rhythm further and is not recommended.

Aaron: That feels like a familiar family flashpoint. Not "screens are evil," but the timing and the child's baseline matter.

Jamie: Yes. And the article's Q&A asks whether ADHD winter depression is more severe, but the text provides prevalence data and an association; it doesn't present direct evidence that it's more severe in ADHD. So we should keep that distinction.

Aaron: Before we close, a smaller piece: ADDitude published a guest blog by Kama Jensen called "Your Concept of Time Is Not Broken, Just Unorthodox." She argues ADHD time difficulties aren't simply a deficit but an unorthodox relationship with time rooted in natural rhythms. She pushes back on "time blind" and suggests clocks can be tools while preserving natural time zones. It's an advice essay, not research.

Jamie: And she explicitly disagrees with most ADHD coaches who say time tools must be everywhere. That's her stated view, not a settled consensus.

Aaron: I like that reframe, as long as it doesn't excuse missing every appointment. The article says people still have to communicate with modern timekeeping. It's about reducing shame, not abandoning tools.

Jamie: Remember, none of this is individual medical advice. You can find links to the original articles on our episode page. Thanks for listening.

Aaron: Thanks. Take care.

References

When a small comment feels like rejection: adult ADHD, rejection sensitive dysphoria, and hiding yourself · Living on the Spectrum